Viatris (VTRS): analysis and statistics
Return, volatility, Sharpe ratio and risk for Viatris, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $17.78 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +24.47% |
| Total return over period | +92.17% |
| Annualized volatility | 32.12% |
| Sharpe ratio | 0.65 |
| Sortino ratio | 0.97 |
| Max drawdown | -45.02% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.27% |
| Correlation with the S&P 500 | 0.34 |
| Period range | $6.89 – $17.86 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Viatris (VTRS) has posted an annualized return of +24.47% with annual volatility of 32.12%, a Sharpe ratio of 0.65. Its worst stretch (max drawdown from a peak) was -45.02%. Its correlation with the S&P 500 is 0.34, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how VTRS would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with VTRS →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio